Monthly Archives: January 2011

Positive Top-Line Results from Combination Study for the Treatment of Gout.

Posted on January 14, 2011 by CCCT

Ardea Biosciences, Inc. (Nasdaq: RDEA) announced positive, preliminary, top-line results from its Phase 2b study of RDEA594 in combination with the current standard of care for the treatment of gout, allopurinol. Allopurinol currently accounts for greater than 90% of the unit … Continue reading →

Posted in Clinical Trial, Gout | 3 Comments